Literature DB >> 8472779

The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987.

M Karvonen1, J Tuomilehto, J Pitkäniemi, P Saikku.   

Abstract

The epidemic cycle of Chlamydia pneumoniae infection was examined in two areas in eastern Finland over a period of 15 years, 1972-87. The C. pneumoniae IgG antibody prevalence was determined with 5-year intervals in a random sample of the population aged 25-59 years. The total number of sera studied using immunofluorescence was 2387. In 1972 the antibody prevalence was 57% and it increased to 66% in 1977. Over the next 5 years the prevalence decreased to 44% in 1982, but by 1987 it had again increased to 59%. The temporal variation in prevalence was statistically significant (P < 0.001) and similar for both genders. Throughout the observation period the overall prevalence was 7-11% higher in men than in women (P < 0.01). The antibody prevalence increased with age, being the highest among the oldest study subjects of both genders. The periods of high and low prevalence alternated in an epidemic cycle (P < 0.001) of about 10 years.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472779      PMCID: PMC2272255          DOI: 10.1017/s0950268800068291

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958.

Authors:  M Karvonen; J Tuomilehto; A Naukkarinen; P Saikku
Journal:  Int J Epidemiol       Date:  1992-04       Impact factor: 7.196

2.  Decline in cardiovascular mortality in North Karelia and other parts of Finland.

Authors:  J Tuomilehto; J Geboers; J T Salonen; A Nissinen; K Kuulasmaa; P Puska
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland.

Authors:  M Kleemola; P Saikku; R Visakorpi; S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

5.  A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR).

Authors:  A Frydén; E Kihlström; R Maller; K Persson; V Romanus; S Anséhn
Journal:  Scand J Infect Dis       Date:  1989

Review 6.  Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases.

Authors:  J T Grayston; S P Wang; C C Kuo; L A Campbell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

7.  International differences in developing improvements in cardiovascular health.

Authors:  Z Pisa; K Uemura
Journal:  Ann Med       Date:  1989-06       Impact factor: 4.709

8.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population.

Authors:  D H Thom; J T Grayston; S P Wang; C C Kuo; J Altman
Journal:  Am J Epidemiol       Date:  1990-08       Impact factor: 4.897

10.  Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.

Authors:  J T Grayston; C Mordhorst; A L Bruu; S Vene; S P Wang
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

View more
  6 in total

1.  Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000.

Authors:  N Miyashita; H Fukano; K Yoshida; Y Niki; T Matsushima
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications.

Authors:  G Ong; B J Thomas; A O Mansfield; B R Davidson; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.

Authors:  Mika Paldanius; Aini Bloigu; Marianne Alho; Maija Leinonen; Pekka Saikku
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

Review 4.  Chlamydia pneumoniae and atherosclerosis.

Authors:  Y K Wong; P J Gallagher; M E Ward
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

5.  Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Authors:  R P Verkooyen; D Willemse; S C Hiep-van Casteren; S A Joulandan; R J Snijder; J M van den Bosch; H P van Helden; M F Peeters; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

6.  Multi-peptide ELISAs overcome cross-reactivity and inadequate sensitivity of conventional Chlamydia pneumoniae serology.

Authors:  Kh Shamsur Rahman; Bernhard Kaltenboeck
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.